Malaria, Leishmaniasis and Shistosomiasis Vector Ecology, Transmission, Immunology and Prophylaxis in Kenya
Midterm rept. 1 Jan 1989-1 Jan 1991,
KENYA MEDICAL RESEARCH INST NAIROBI
Pagination or Media Count:
A malaria vaccine evaluation site at Saradidi, Kenya, has been characterized for epidemiological, entomological and demographic parameters over a two year period. The transmission of flaciparum malaria by Anopheles gambiae s.l. and A. funestus was found to be intense year-round. An evaluation of a WRAIR-developed malaria sporozoite vaccine, R32ToxA, was begun in April, 1990, with 38 pairs of volunteers. Leishmaniasis studies have described several parasite-vector-host relationships previously unreported in East Africa which may be important in the diagnosis or control of the disease. In particular, the isolation of two species of leishmania differing drug sensitivity profiles from a single patient is notable. Collaborative development of a vector-induced model for infection in vervet monkeys has significant potential for vaccine evaluation in a non-human model.
- Medicine and Medical Research